Kenji Ezoe: Can Prolactin Improve Embyo Transfer Outcomes?
Kenji Ezoe, Senior Scientist at Kato Ladies Clinic, shared a post on LinkedIn:
“New Publication
Can prolactin improve embryo transfer outcomes?
Our randomized controlled trial, recently published in Reproductive BioMedicine Online, explored the effect of combining prolactin (PRL) with a hyaluronic-acid–enriched transfer medium (EmbryoGlue) for single vitrified-warmed blastocyst transfer (SVBT).
In a double-blind RCT of 1,236 couples, the EGP group (EmbryoGlue + PRL) showed:
- Higher live birth rate
- Higher ongoing pregnancy rate
- Lower early pregnancy loss
compared with both the control and EmbryoGlue groups, with no increase in adverse outcomes.
These findings suggest that PRL supplementation during embryo transfer may help improve live birth outcomes by reducing early pregnancy loss.
Title: Post-warming culture and single vitrified-warmed blastocyst transfer with hyaluronic acid and prolactin: a randomized controlled trial
Authors: Kenji Ezoe, Tetsuya Miki, Nanoha Fujiwara, Satoshi Ueno, Mika Narisawa, Kiyoe Shimazaki, Ryosuke Akino, Shogo Nishii, Sachie Onogi, Satoshi Tsuchiyama, Keiko Wada, Tomoko Kuroda, David K. Gardner, Keiichi Kato
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment